Volume 29, Issue 4 pp. 224-227
Therapeutic Hotline

Primary cutaneous anaplastic large-cell lymphoma: a case report

Can Cao

Can Cao

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Kang Zeng

Kang Zeng

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Menglei Wang

Menglei Wang

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Kai Han

Kai Han

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Yusheng Peng

Yusheng Peng

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Hao Xiong

Hao Xiong

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Qi Wang

Qi Wang

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Qian Li

Qian Li

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Qian Wang

Qian Wang

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Search for more papers by this author
Li Li

Corresponding Author

Li Li

Department of dermatology, Nan Fang Hospital, Guangzhou, China

Address correspondence and reprint requests to: Li Li, MD, Department of Dermatology, Nan Fang Hospital, Guangzhou 510000, China or email: [email protected].Search for more papers by this author
First published: 11 March 2016
Citations: 2

ABSTRACT

Primary cutaneous anaplastic large-cell lymphoma (PCALCL) is a part of the spectrum of CD30+ lymphoproliferative cutaneous processes. The characteristics include single or multifocal nodules that ulcerate as skin lesion, slow disease progression, autoregressive, and recurrent in few years. The present study report the case of a 16-year-old boy presenting PCALCL with single nodules, ulcer, keloid, and scab in his right-side face. He showed a good response to the treatment with systemic chemotherapy and dermatoplasty, and regained confidence after the appearance of recovery. There is no relapse of the primary lesion and organs involved till now. The chemotherapy combining with surgical excision and dermatoplasty is a good method for PCALCL, per the lesion biopsy and positron emission tomography-computed tomography before and after treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.